Resources
For the latest in precision medicine, sign up for our monthly newsletter to be among the first to receive
exclusive insights, in-depth market analyses, and expert articles directly to your inbox

On-demand webinar presented by Mo Jain, MD, PhD, Founder and CEO, Sapient and Jonathan Usuka, PhD, MBA Chief Business Officer, Sapient

Accelerate Protein Screening by Sequencing Protein Barcodes on Platinum®
On-demand webinar presented by Joel McDade, PhD, Sr. Commercial Business Development Manager, Quantum-Si and Bonnie Lun, PhD, Field Application Scientist

Challenges and Strategies for the Application of Omics and Spatial Technologies
A concise report featuring insights from the prominent thought leaders of Omics 2023 and Spatial 2024

Top R&D Stories of 2023
Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.

Biomarker Discovery & Development
Are Neuroimmune Proteins the Key to Neurodegenerative Disease Diagnosis?
Unique neuroinflammatory signatures and pathways present in tauopathies could provide greater insight into distinct mechanisms of disease.

Clinical Development
Implementing Patient-Centricity into Biomarker Clinical Trials
How can we better define patient-centric clinical trials within the drug development process?

Clinical Diagnostics
Spatial Analysis of TME Microglia in Melanoma Brain Metastasis
The therapeutic targeting of TME microglia activity may improve the efficacy of treatments for melanoma brain metastasis. Future research could represent a new opportunity in confronting one of the most difficult cancers to treat.

Spatial Analysis
The Spatial Biology Week 2022. Watch now on-demand
Your front-row seat to world innovators

Clinical Development
Cervical Indicators of HIV Risk Found
Study finds predictive link between genital herpes and HIV.

Diagnostic Development
Predicting Preeclampsia Risk with Placental Proteins
A new study by Cedars-Sinai could identify protein biomarkers for preeclampsia.

Clinical Development
Novel Microbial Immunotherapies for Bladder Cancer Treatment
The potential oncolytic applications of Salmonella ZH9 include its use in mitigating diseases such as bladder cancer, with a demonstrated therapeutic effect in cancer models.

Clinical Development
Patient Engagement in Biomarker Development
Christopher Conn, Director of Diagnostics Strategy at Amgen, leads a Discussion Group on patient testing and engagement in biomarker clinical trials.

Biomarker Discovery & Development
Biomarker Testing Consolidation and Implementation Using Multiplex Immunofluorescence
Multiplex immunofluorescence is gaining prevalence in oncology diagnostics; what makes it so effective, and how is it being brought into the clinic?

Clinical Development
Biomarkers for NASH Symposium: Most Anticipated Presentation
Discover key event highlights from Oxford Global's upcoming Biomarkers for NASH Symposium 2022.

Clinical Development
Scientists at Stanford Medicine Predict Who Will Develop Vaccine Immunity
A gene signature found in antibody-producing cells could accelerate vaccine development.

Biomarker Discovery & Development
New Therapeutic Target for Aggressive Breast Cancer
Scientists at VCU Massey Cancer Center pinpoint druggable target in aggressive breast cancer.
Subscribe to Our Newsletter
Sign up for our monthly newsletter to
keep up with all things discovery